Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.27T
Market cap1.27T
Price-Earnings ratio
44.48
Price-Earnings ratio44.48
Dividend yield
0.49%
Dividend yield0.49%
Average volume
3.46M
Average volume3.46M
High today
$1,377.28
High today$1,377.28
Low today
$1,333.22
Low today$1,333.22
Open price
$1,350.45
Open price$1,350.45
Volume
3.81M
Volume3.81M
52 Week high
$1,453.00
52 Week high$1,453.00
52 Week low
$850.51
52 Week low$850.51

Stock Snapshot

With a market cap of 1.27T, Eli Lilly(LLY) trades at $1,357.00. The stock has a price-to-earnings ratio of 44.48 and currently yields dividends of 0.49%.

During the trading session on 2026-11-08, Eli Lilly(LLY) shares reached a daily high of $1,377.28 and a low of $1,333.22. At a current price of $1,357.00, the stock is +1.8% higher than the low and still -1.5% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 3.81M, versus its average volume of 3.46M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.

LLY News

Simply Wall St 21h
Is Hims & Hers Health A Bargain After Its Lilly Deal? - Simply Wall St

...

Is Hims & Hers Health A Bargain After Its Lilly Deal? - Simply Wall St
The Motley Fool 1d
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials

Eli Lilly (LLY -0.79%) is much loved on Wall Street because of its highly successful GLP-1 weight-loss business. Novo Nordisk (NVO +0.03%) is much less apprecia...

Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials
Simply Wall St 1d
Hims Partnership Could Be A Big Deal For Eli Lilly

Eli Lilly and Hims & Hers Health announced a partnership in early November 2026 that lets eligible patients obtain Zepbound and Foundayo on the Hims & Hers tele...

Hims Partnership Could Be A Big Deal For Eli Lilly

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

The Motley Fool 1d
Eli Lilly Just Raised Its 2026 Revenue Forecast by $5.5 Billion. Is the Stock Still a Buy?

After a 57% run-up over the past 52 weeks, Eli Lilly (LLY -0.79%) shares are expensive. The stock is now trading at 47 times trailing earnings. That's more than...

Eli Lilly Just Raised Its 2026 Revenue Forecast by $5.5 Billion. Is the Stock Still a Buy?
The Motley Fool 2d
Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the Evidence

Eli Lilly's (LLY -0.79%) impressive run continues. The company's recent third-quarter update was excellent, sending the stock price up about 6%. Eli Lilly's wei...

Eli Lilly Is Much More Than a Weight-Loss Drug Company. Here's the Evidence
Simply Wall St 2d
Eli Lilly Widens Access To Its Obesity Drugs Through Telehealth

Eli Lilly (NYSE:LLY) is partnering with Hims & Hers Health and LifeMD to offer FDA-approved obesity drugs through telehealth platforms. The collaborations give...

Eli Lilly Widens Access To Its Obesity Drugs Through Telehealth
Benzinga 2d
Telehealth Giant Hims & Hers Partners with Eli Lilly for Direct Weight Loss Drug Delivery

On Friday, Eli Lilly And Co. (NYSE:LLY) and Hims & Hers Health Inc. (NYSE:HIMS) announced a collaboration to broaden patient access to obesity medications Zepbo...

Telehealth Giant Hims & Hers Partners with Eli Lilly for Direct Weight Loss Drug Delivery
TipRanks 2d
Hims & Hers Stock Jumps Ahead of Q3 Earnings on Nov. 9 — Here’s Why

Hims & Hers Health shares (HIMS) jumped 6% to about $25 on Friday morning, erasing some of the roughly 10% drop the previous day. This followed a statement from...

MarketWatch 2d
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Hims & Hers Health announced a new arrangement with Eli Lilly that allows patients to purchase the drugmaker’s GLP-1 medications directly through its platform....

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
TipRanks 3d
Eli Lilly Updates Early Imlunestrant Study as Investors Watch Cancer Pipeline Progress

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly’s Phase 1 study, titled “A Phase 1, Open-Label, 4-Pa...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.